Top-News
Pharmazeutika Indien

Dr Reddy's Laboratories News

Aktie
WKN:  659157 ISIN:  US2561352038 US-Symbol:  RDY
62,50 €
-2,00 €
-3,10%
31.05.24 21:43:23
Handeln Depot/Watchlist
Aktienanzahl *
166,21 Mio.
Marktkapitalisierung *
10,52 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
DBIX Deutsche Börse India EUR (Performance)
IR-Website
zur Website
*Stand: 24.08.2023

Dr Reddy's Laboratories News

22.03.24 - wallstreet:online Zentralredaktion
Incredible India: Gehört Indien die Zukunft? Aktien, ETFs und Fonds aus dem Land der Gegensätze
Der indische Markt entwickelt sich stärker als europäische und US-​Leitindizes. Erfahren Sie, welche Faktoren die Entwicklung begünstigen und welche Aktien, ETFs und Fonds zur ...
13.04.22 - wallstreet:online Zentralredaktion
Rendite-Liste: Bernstein: Diese Indien-Aktien könnten um zehn Prozent und mehr steigen
Foto: Free-​Photos - pixabay.com Indische Aktien mit mehr als zehn Prozent Aufwärtspotenzial haben Bernstein-​Analysten gefunden. Eine hätte gar das Potential, um an die 40 ...
07.09.21 - PR Newswire
Citius Pharmaceuticals Acquires Dr. Reddy's Laboratories' License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indications
Citius Pharmaceuticals Acquires Dr. Reddy's Laboratories' License for Late-​Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other ...
03.06.21 - PR Newswire
Global Response Aid Reports Midyear Sales Results for COVID Drug
Global Response Aid Reports Midyear Sales Results for COVID Drug Reports sales of 11 million anti-​viral Avigan® tablets in first seven months PR Newswire
03.03.21 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY PR Newswire
02.02.21 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY PR Newswire
06.02.20 - PR Newswire
Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170
Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170 - Aurigene to fund and conduct a Phase 2b/3 randomized study of ...
20.07.19 - PR Newswire
Upsher-Smith Laboratories Completes Acquisition Of Two Treatments For Acute Migraine In Adults
Upsher-​Smith Laboratories Completes Acquisition Of Two Treatments For Acute Migraine In Adults Strategic Acquisition of Tosymra™ (sumatriptan) Nasal Spray and Zembrace® ...
13.06.19 - PR Newswire
Upsher-Smith Laboratories Enters Into Agreement To Acquire Tosymra™ (sumatriptan nasal spray) And Zembrace® SymTouch® (sumatriptan injection)
Upsher-​Smith Laboratories Enters Into Agreement To Acquire Tosymra™ (sumatriptan nasal spray) And Zembrace® SymTouch® (sumatriptan injection) Strategic Acquisition ...
01.05.19 - PR Newswire
URGENT: Monteverde & Associates PC Invites Dr. Reddy's Laboratories Ltd. Shareholders or Former Shareholders To Contact the Firm Immediately
URGENT: Monteverde & Associates PC Invites Dr. Reddy's Laboratories Ltd. Shareholders or Former Shareholders To Contact the Firm Immediately PR Newswire
19.07.18 - PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dr. Reddy's Laboratories Limited (RDY)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dr. Reddy's Laboratories Limited (RDY) PR Newswire
15.06.18 - PR Newswire
Dr. Reddy's Laboratories announces USFDA final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. Market
Dr. Reddy's Laboratories announces USFDA final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. Market PR Newswire
21.03.18 - The Motley Fool
3 Dinge, die die Investoren von Celgene nach dem Ozanimod-Debakel wissen möchten
Die Geschichte von Celgene (WKN:881244) könnte aus einem traurigen Country-​Song kommen. Das große Biotech-​Unternehmen hat in den vergangenen sechs Monaten mehr ...
18.10.17 - PR Newswire
EQUITY ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited
EQUITY ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited PR Newswire
13.10.17 - PR Newswire
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. - RDY
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. - RDY PR Newswire
11.10.17 - PR Newswire
DR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Dr. Reddy's Laboratories Limited To Contact The Firm
DR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Dr. Reddy's Laboratories Limited To Contact The Firm ...
22.09.17 - PR Newswire
DR. REDDY'S SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. - (RDY)
DR. REDDY'S SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dr. ...
15.09.17 - PR Newswire
DR. REDDY'S SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Ag
DR. REDDY'S SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 ...
06.09.17 - PR Newswire
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with ...
05.09.17 - PR Newswire
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with ...

Newssuche

Videos

newspaper
29.05.24
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »